Sartorius Stedim Biotech SA - Company Profile

Powered by

All the data and insights you need on Sartorius Stedim Biotech SA in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Sartorius Stedim Biotech SA Strategy Report

  • Understand Sartorius Stedim Biotech SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Sartorius Stedim Biotech SA: Overview

Select Item

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, filters, bioreactors, shakers, virus purification kits and centrifuges, among others. SSB’s services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.

 Gain a 360-degree view of Sartorius Stedim Biotech SA and make more informed decisions for your business Gain a 360-degree view of Sartorius Stedim Biotech SA and make more informed decisions for your business Find out more
Headquarters France
Address Bp 1051, Aubagne Cedex, Provence - Alpes- Cote d'Azur, 13781
Website www.sartorius.com/en/company/about-sartorius-stedi
Telephone 33 4 42845600
No of Employees 10,849
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange DIM (EPA)
Revenue (2022) $3.7B 21% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 111.4% (2022 vs 2021)
Market Cap* $25.8B
Net Profit Margin (2022) XYZ 74.8% (2022 vs 2021)
* As of and is in US$
View Sartorius Stedim Biotech SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Sartorius Stedim Biotech SA premium industry data and analytics

3

Clinical Trials

Determine Sartorius Stedim Biotech SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

Pipeline Drugs

Identify which of Sartorius Stedim Biotech SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Sartorius Stedim Biotech SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Cell Analysis Bioprocess Development & Engineering: Ambr
Cell Culture Media and Buffers Basic Engineering Cubis
Bioreactors and Fermenters Conceptual Design Flexsafe
XYZ XYZ XYZ
XYZ XYZ XYZ
XYZ XYZ XYZ
Understand Sartorius Stedim Biotech SA portfolio and identify potential areas for collaboration Understand Sartorius Stedim Biotech SA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Acquisitions/Mergers/Takeovers In July, the company acquired Polyplus.
2023 Contracts/Agreements In June, the company and Waters Corp entered into a partnership to develop integrated analytical solutions for downstream biomanufacturing.
2023 Contracts/Agreements In April, the company entered into a partnership with va-Q-tec to optimize logistics for shipping bulk drug substances (BDS).
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Sartorius Stedim Biotech SA Thermo Fisher Scientific Inc Danaher Corp Merck KGaA Bio-Rad Laboratories Inc
Headquarters France United States of America United States of America Germany United States of America
City Aubagne Waltham Washington Darmstadt Hercules
State/Province Provence - Alpes- Cote d'Azur Massachusetts WashingtonD.C. Hessen California
No. of Employees 10,849 130,000 79,000 63,297 8,200
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Joachim Kreuzburg Chairman Executive Board 2007 57
Rene Faber Chief Executive Officer Senior Management 2023 47
Christelle Baudere Director Non Executive Board 2021 48
Pascale Boissel Director Non Executive Board 2019 56
Susan Dexter Director Non Executive Board 2015 67
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Sartorius Stedim Biotech SA key executives to enhance your sales strategy Gain insight into Sartorius Stedim Biotech SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward